openPR Logo
Press release

blue inspection body GmbH strengthens the team for global API audits with Bohong Meng

05-12-2011 04:56 PM CET | Health & Medicine

Press release from: blue inspection body GmbH

/ PR Agency: co-operate Wegener & Rieke GmbH
Bohong Meng is responsible at blue inspection body GmbH for GMP audits of active pharmaceutical ingredients.

Bohong Meng is responsible at blue inspection body GmbH for GMP audits of active pharmaceutical ingredients.

Münster (Germany), 12 Mai 2011. Starting beginning of May Bohong Meng joined the team of auditors at blue inspection body GmbH (blue-inspection.com) in Münster, Germany. She will be assessing the Good Manufacturing Practices of active pharmaceutical ingredient (API) suppliers for the third-party audit service provider on behalf of pharmaceutical companies. The main focus of her activities will be the monitoring of Asian manufacturers. „This region of the world shows the highest demand for qualified GMP audits“, comments the General Manager of blue Dr. Stefan Kettelhoit. „About 80% of the APIs for European medicinal products are sourced from countries such as China or India.“ After passing the Bachelor degree for International Finance and Laws at the Dalian Maritime University in China Bohong Meng studied Pharmacy at the University Erlangen-Nürnberg, Germany. For blue inspection body GmbH she will at first be starting as Co-Auditor.

(approx. 950 characters)

The blue inspection body GmbH examines the Good Manufacturing Practice (GMP) of pharmaceutical companies around the globe. Third-party audits by blue efficiently relieve manufacturing authorisation holders, API suppliers and API manufacturers. Blue inspection body GmbH is the first independent and accredited service provider for GMP audits in the European Union.

Contact:
blue inspection body GmbH
Hafenweg 18-20
D-48155 Münster

Contact person:
Dr. Stefan Kettelhoit

Phone: +49 (0)251 - 625620-40
stefan.kettelhoit@blue-inspection.com
www.blue-inspection.com

Agency contact:
co-operate Wegener & Rieke GmbH
Zumsandeplatz 32
D-48145 Münster

Contact person:
Christian Rieke

Tel.: +49 (0)251 - 3222611
wort@co-operate.net
www.co-operate.net

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release blue inspection body GmbH strengthens the team for global API audits with Bohong Meng here

News-ID: 174763 • Views:

More Releases from blue inspection body GmbH

blue inspection body reports on experiences with excipient audits
blue inspection body reports on experiences with excipient audits
The industry initiative EXCiPACT was launched a year ago to improve monitoring of pharmaceutical excipients. At the CPhI China in Shanghai and the ExcipientFest Europe in Amsterdam, the auditors of blue inspection body (www.blue-inspection.com) have now drawn an initial conclusion: “Overall, the level of awareness for Good Manufacturing and Good Distribution Practices at excipient manufacturers has increased significantly in the past twelve months,” declared lead auditor Dr. Norbert Waldöfner in
Aiming for tighter surveillance of excipients used in medicines
Baltimore (USA), Münster (DE), 06 May 2013. The EXCiPACT certification scheme, an initiative of industrial associations from excipient and pharma suppliers, has officially been launched in the US. EXCiPACT is aiming for an independent and impartial monitoring of Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) compliance. The manufacturing and distribution operations of excipient suppliers will be subject to regular on-site monitoring by auditors from accredited Certification Bodies. A
Manufacturers of Pharma-Excipients aiming for certified monitoring
Muenster, 29 November 2012. Supported by extensive professional knowledge of blue inspection body GmbH, the mdc medical device certification GmbH represents the first European Certification Body for pharmaceutical excipients. mdc and EXCiPACT have signed a respective framework agreement. The EXCiPACT certification scheme is an initiative of industrial associations from excipient and pharma suppliers, aiming for a professional surveillance of Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) compliance. The
Blue Inspection Body audits Good Manufacturing Practice compliance of Biotec-der …
Muenster (Germany), 16 March 2012. The first accredited Good Manufacturing Practice (GMP) inspection body in Europe broadens its range of services: blue inspection body (www.blue-inspection.com) successfully completed an audit of an antibody manufacturing site for a Russian pharmaceutical company. The contract giver, OOO NPF MATERIA MEDICA HOLDING, uses the Biotech-derived glycoprotein for manufacturing homoeopathic medicinal products supplied to the Russian market. Pharmaceutical manufacturers must verify compliance with GMP standards along the

All 5 Releases


More Releases for GMP

Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides. As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EU
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp. This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008. “ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures. The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,